CORC

在结果中检索

CORC

浏览/检索结果: 共12条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Axitinib vs placebo in patients at high risk of recurrent renal cell carcinoma (RCC): ATLAS trial results 会议论文
作者:  Gross-Goupil, M.;  Kwon, T. G.;  Eto, M.;  Ye, D.;  Miyake, H.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 18
作者:  Xiong, Zuquan;  Zang, Yiwen;  Zhong, Shan;  Zou, Lujia;  Wu, Yishuo
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma 期刊论文
JOURNAL OF CANCER, 2016, 卷号: 7, 期号: 10
作者:  Wang, Hongkai;  Wu, Junlong;  Gu, Weijie;  Wang, Beihe;  Wan, Fangning
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/06
Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma 期刊论文
BJU INTERNATIONAL, 2016, 卷号: 117, 期号: 2
作者:  Liu, Li;  Xu, Zhibing;  Zhong, Lei;  Wang, Hang;  Jiang, Shuai
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/06
kidney cancer  RCC  EZH2  EMT  survival  DZNep  
Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study 期刊论文
ONCOTARGET, 2015, 卷号: 6, 期号: 34
作者:  Zhang, Hai-Liang;  Qin, Xiao-Jian;  Wang, Hong-Kai;  Gu, Wei-Jie;  Ma, Chun-Guang
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19
ATLAS study: A randomized double-blind phase 3 study of adjuvant axitinib versus placebo in subjects at high risk of recurrent renal cell carcinoma (RCC) 期刊论文
Journal of Clinical Oncology, 2014, 卷号: 32
作者:  Kwon T.G., Seong S., Byun S.-S., Miyake H., Ueda T., Ye D., Garc铆a-Donas J., Gross-Goupil M., Hutson T.E., DeBenedetto R., Hariharan S., Lee M.Y., Linke R.G., Tsuji F., Quinn D.I.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
Use of Targeted Therapies for Advanced Renal Cell Carcinoma in the Asia-Pacific Region: Opinion Statement From China, Japan, Taiwan, Korea, and Australia 期刊论文
CLINICAL GENITOURINARY CANCER, 2014, 卷号: 12, 期号: 4
作者:  Ye, Dingwei;  Eto, Masatoshi;  Chung, Jin Soo;  Kimura, Go;  Chang, Wen-Cheng
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19
Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China 期刊论文
BJU INTERNATIONAL, 2014, 卷号: 114, 期号: 4
作者:  Wang, Hong-Kai;  Song, Xi-Shuang;  Cheng, Yue;  Qu, Yuan-Yuan;  Zhang, Shi-Lin
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19
ATLAS study: A randomized double-blind phase 3 study of adjuvant axitinib versus placebo in subjects at high risk of recurrent renal cell carcinoma (RCC). 会议论文
作者:  Kwon, Tae Gyun;  Seong, Seo;  Byun, Seok-Soo;  Miyake, Hideaki;  Ueda, Takeshi
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
Sorafenib treatment of Asian patients with advanced renal cell carcinoma (RCC) in daily practice: Subset analysis of the large non-interventional PREDICT study 期刊论文
Journal of Clinical Oncology, 2012, 卷号: 30
作者:  Ye D., Guo J., Lee J.-L., Zhou A.-P., Huang Y., Hu Z., Fu C., Liu J., Qi L., Li H., Zou Q., Hong S.J., Stauch K., B?ckenhoff A., Kim G., Zhang X.J., Ahn H., Ma J.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace